Expression of NM23-M1 and NM23-M2 in primary melanomas of the HGF+ × [m1m2]+/− group remained at the expected 50 % reduced levels relative to those obtained in HGF+ mice (Supplemental Fig. 2). The gene discussed is NME1; the disease is melanoma.